Literature DB >> 19967049

Expression of endothelin-1 and its receptors in Cisplatin-induced acute renal failure in mice.

Seokwoo Lee1, Dowhan Ahn.   

Abstract

Endothelin-1 (ET-1) is unequivocally elevated in the kidney with ischemic acute renal failure (ARF), whereas ET receptors (ET(A)R and ET(B)R) are variably expressed. Although renal functional and structural changes are similar between ischemic and nephrotoxic ARF, there are few reports on the alteration in the ET system in nephrotoxic ARF. This study was, therefore, undertaken to investigate changes in renal expression of ET-1 and its receptors in nephrotoxic ARF induced by cisplatin. Mice were intraperitoneally injected with 16 mg of cisplatin/kg at a single dose, and the expression of mRNA and protein was then quantified by real-time RT-PCR and Western blot, respectively. Immunohistochemistry was conducted for localization. Three days after treatment, ET-1 transcript in cisplatin-treated mice was thirteen times higher than that in controls, whereas ET-1 peptide was increased by 1.5-fold. Cisplatin caused a 2-fold increase in the levels of ET(A)R mRNA and protein. Most of the increased immunoreactive ET-1 and ET(A)R were localized in damaged tubules. Neither the expression of ET(B)R mRNA nor the abundance and immunoreactive level of ET(B)R protein were changed. The findings suggest that the individual components of the renal ET system are differentially regulated in cisplatin-induced nephrotoxic ARF.

Entities:  

Keywords:  Acute renal failure; Cisplatin; Endothelin; Endothelin receptor

Year:  2008        PMID: 19967049      PMCID: PMC2788629          DOI: 10.4196/kjpp.2008.12.4.149

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  20 in total

1.  Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats.

Authors:  T Kuro; K Kohnou; Y Kobayashi; M Takaoka; T J Opgenorth; J L Wessale; Y Matsumura
Journal:  Jpn J Pharmacol       Date:  2000-04

Review 2.  Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?

Authors:  Christos Chatziantoniou; Jean-Claude Dussaule
Journal:  Am J Physiol Renal Physiol       Date:  2005-08

3.  Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.

Authors:  C Braun; T Conzelmann; S Vetter; M Schaub; W E Back; B Yard; M Kirchengast; S G Tullius; P Schnülle; F J van der Woude; P Rohmeiss
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

4.  Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis.

Authors:  T Nakamura; I Ebihara; M Fukui; S Osada; Y Tomino; T Masaki; K Goto; Y Furuichi; H Koide
Journal:  J Am Soc Nephrol       Date:  1995-02       Impact factor: 10.121

5.  Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity.

Authors:  A Hoffman; E Grossman; D S Goldstein; J R Gill; H R Keiser
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

6.  Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat.

Authors:  A Yoshimura; S Iwasaki; K Inui; T Ideura; S Koshikawa; M Yanagisawa; T Masaki
Journal:  Kidney Int       Date:  1995-10       Impact factor: 10.612

7.  Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats.

Authors:  T Shimizu; T Kuroda; M Ikeda; S Hata; M Fujimoto
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

8.  Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.

Authors:  P Roubert; V Gillard-Roubert; L Pourmarin; S Cornet; C Guilmard; P Plas; E Pirotzky; P E Chabrier; P Braquet
Journal:  Mol Pharmacol       Date:  1994-02       Impact factor: 4.436

9.  Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat.

Authors:  M Gellai; M Jugus; T Fletcher; R DeWolf; P Nambi
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Improvement of postischemic acute renal failure with the novel orally active endothelin-A receptor antagonist LU 135252 in the rat.

Authors:  R Birck; T Knoll; C Braun; M Kirchengast; K Münter; F J van der Woude; P Rohmeiss
Journal:  J Cardiovasc Pharmacol       Date:  1998-07       Impact factor: 3.105

View more
  6 in total

Review 1.  Regulation of sodium transport in the proximal tubule by endothelin.

Authors:  Ye Zhang; Pedro A Jose; Chunyu Zeng
Journal:  Contrib Nephrol       Date:  2011-08-30       Impact factor: 1.580

2.  Role of endothelin-1 antagonist; bosentan, against cisplatin-induced nephrotoxicity in male and female rats.

Authors:  Zahra Jokar; Mehdi Nematbakhsh; Maryam Moeini; Ardeshir Talebi
Journal:  Adv Biomed Res       Date:  2015-05-11

3.  Endothelin inhibits renin release from juxtaglomerular cells via endothelin receptors A and B via a transient receptor potential canonical-mediated pathway.

Authors:  M Cecilia Ortiz-Capisano
Journal:  Physiol Rep       Date:  2014-12-18

4.  Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner.

Authors:  Bojana Simovic Markovic; Marina Gazdic; Aleksandar Arsenijevic; Nemanja Jovicic; Jovana Jeremic; Valentin Djonov; Nebojsa Arsenijevic; Miodrag L Lukic; Vladislav Volarevic
Journal:  Stem Cells Int       Date:  2017-07-30       Impact factor: 5.443

5.  The Urinary Level of Injury Biomarkers Is Not Univocally Reflective of the Extent of Toxic Renal Tubular Injury in Rats.

Authors:  Sandra M Sancho-Martínez; María Herrero; Miguel Fontecha-Barriuso; Joana Mercado-Hernández; Francisco J López-Hernández
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

6.  Role of endothelin receptor antagonist; bosentan in cisplatin-induced nephrotoxicity in ovariectomized estradiol treated rats.

Authors:  Alieh Zahedi; Mehdi Nematbakhsh; Maryam Moeini; Ardeshir Talebi
Journal:  J Nephropathol       Date:  2015-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.